A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (PROFILE 1001)

Clinical Trial ID NCT00585195

PubWeight™ 139.78^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00585195

Top papers